MacKay Shields »

Halozyme Therapeutics shares owned by MacKay Shields

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by MacKay Shields from 13F filings

Historical chart of MacKay Shields investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by MacKay Shields consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by MacKay Shields

Quarter filed Position value Share count Share price at filing
2025-09-30 $58M 51M 1.14
2023-06-30 $32k 38k 0.84
2023-03-31 $24k 28k 0.85
2022-12-31 $27k 28k 0.97
2022-09-30 $6.6M 7.7M 0.85
2022-06-30 $6.8M 7.7M 0.89
2022-03-31 $6.8M 7.7M 0.88